Clinical Trial Results:
A Randomised, Double-Blind, Double-Dummy Cross-Over Study to demonstrate Superiority of Fluticasone/ Salmeterol pMDI over double the dose of Fluticasone pMDI on Methacholine Hyper-Reactivity in Patients with Persistent, Mild to Moderate Asthma (as defined by GINA guidelines).
Summary
|
|
EudraCT number |
2008-001027-59 |
Trial protocol |
GB |
Global completion date |
04 May 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 May 2016
|
First version publication date |
28 May 2016
|
Other versions |
|
Summary report(s) |
CLE001 Summary Results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.